Drug Name: Jesduvroq

Indications: To treat anemia caused by chronic kidney disease for adults on dialysis for at least four months.

Active Ingredient: Daprodustat

Company: GlaxoSmithKline

Approval Date: 2/1/2023

More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216951s000lbl.pdf

Leave a Reply

Your email address will not be published. Required fields are marked *